{
    "Trade/Device Name(s)": [
        "Thermo Scientific CEDIA Cocaine OFT Assay",
        "CEDIA Cocaine OFT Assay",
        "CEDIA\u00ae Cocaine OFT Assay"
    ],
    "Submitter Information": "Thermo Fisher Scientific, Clinical Diagnostic Division",
    "510(k) Number": "K101742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001197"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO"
    ],
    "Summary Letter Date": "April 6, 2011",
    "Summary Letter Received Date": "April 7, 2011",
    "Submission Date": "January 6, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.3250"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Cocaine",
        "Benzoylecgonine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Oral-Eze Saliva Collection System"
    ],
    "Instrument(s)/Platform(s)": [
        "MGC240"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Recombinant DNA technology",
        "Homogeneous enzyme immunoassay system"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Thermo Scientific CEDIA Cocaine OFT Assay for qualitative determination of cocaine in oral fluid using enzyme immunoassay on the MGC240.",
    "Indications for Use Summary": "Qualitative determination of cocaine in human oral fluid at a 15 ng/mL cutoff, with specimens collected via Oral-Eze Saliva Collection System and testing performed on the MGC240, for clinical laboratory use only.",
    "fda_folder": "Toxicology"
}